{"AllianceGenome": "9299", "HGNC": "9299", "MIM": "176915", "_id": "5515", "_version": 1, "accession": {"genomic": ["AC104109.3", "CH471062.2", "CP068273.2", "M60483.1", "NC_000005.10", "NC_060929.1", "NG_046997.2"], "protein": ["AAA36466.1", "AAB38019.1", "AAH00400.1", "AAH02657.1", "AAH19275.1", "AAH31696.1", "BAG51913.1", "BAG53493.1", "BAG70054.1", "BAG70179.1", "CAA31176.1", "CAG33698.1", "EAW62268.1", "EAW62269.1", "NP_001341948.1", "NP_002706.1", "P67775.1"], "rna": ["AB451240.1", "AB451365.1", "AK057424.1", "AK097599.1", "AV705728.1", "BC000400.2", "BC002657.2", "BC019275.1", "BC031696.1", "BM786995.1", "CR457417.1", "J03804.1", "NM_001355019.2", "NM_002715.4", "NR_149151.2", "X12646.1"], "translation": [{"protein": "AAH02657.1", "rna": "BC002657.2"}, {"protein": "CAG33698.1", "rna": "CR457417.1"}, {"protein": "BAG53493.1", "rna": "AK097599.1"}, {"protein": "AAB38019.1", "rna": "J03804.1"}, {"protein": "AAH31696.1", "rna": "BC031696.1"}, {"protein": "NP_002706.1", "rna": "NM_002715.4"}, {"protein": "AAH19275.1", "rna": "BC019275.1"}, {"protein": "BAG70179.1", "rna": "AB451365.1"}, {"protein": "NP_001341948.1", "rna": "NM_001355019.2"}, {"protein": "AAH00400.1", "rna": "BC000400.2"}, {"protein": "CAA31176.1", "rna": "X12646.1"}, {"protein": "BAG51913.1", "rna": "AK057424.1"}, {"protein": "BAG70054.1", "rna": "AB451240.1"}]}, "alias": ["HJS3", "NEDLBA", "PP2Ac", "PP2CA", "PP2Calpha", "RP-C"], "ec": "3.1.3.16", "ensembl": {"gene": "ENSG00000113575", "protein": ["ENSP00000418447", "ENSP00000428816", "ENSP00000430869", "ENSP00000515254", "ENSP00000515255", "ENSP00000515256", "ENSP00000515257", "ENSP00000515268"], "transcript": ["ENST00000231504", "ENST00000472253", "ENST00000481195", "ENST00000495833", "ENST00000522385", "ENST00000523082", "ENST00000703308", "ENST00000703309", "ENST00000703310", "ENST00000703311", "ENST00000703354", "ENST00000703359"], "translation": [{"protein": "ENSP00000515268", "rna": "ENST00000703354"}, {"protein": "ENSP00000418447", "rna": "ENST00000481195"}, {"protein": "ENSP00000515254", "rna": "ENST00000703308"}, {"protein": "ENSP00000515255", "rna": "ENST00000703309"}, {"protein": "ENSP00000515256", "rna": "ENST00000703310"}, {"protein": "ENSP00000515257", "rna": "ENST00000703311"}, {"protein": "ENSP00000430869", "rna": "ENST00000522385"}, {"protein": "ENSP00000428816", "rna": "ENST00000523082"}], "type_of_gene": "protein_coding"}, "entrezgene": "5515", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.5560732461, "exp_mis": 111.65495477, "exp_syn": 43.968244627, "lof_z": 3.51007629984586, "mis_z": 4.47405899450826, "mu_lof": 8.77492857335e-07, "mu_mis": 9.8858584823e-06, "mu_syn": 3.69967317837e-06, "n_lof": 0.0, "n_mis": 15.0, "n_syn": 47.0, "p_li": 0.985509347938547, "p_null": 7.25612976759733e-06, "p_rec": 0.0144833959316858, "syn_z": -0.283448886379728}, "bp": 930, "cds_end": 133561552, "cds_start": 133533462, "n_exons": 7, "nonpsych": {"exp_lof": 11.2238124622, "exp_mis": 100.917866094, "exp_syn": 39.6548596965, "lof_z": 3.29019868684498, "mis_z": 4.46443764682051, "mu_lof": 8.77492857335e-07, "mu_mis": 9.8858584823e-06, "mu_syn": 3.69967317837e-06, "n_lof": 0.0, "n_mis": 12.0, "n_syn": 40.0, "p_li": 0.979296925768005, "p_null": 2.12662019970363e-05, "p_rec": 0.0206818080299979, "syn_z": -0.0345072674352362}, "nontcga": {"exp_lof": 11.537878567, "exp_mis": 102.708856567, "exp_syn": 40.4370784454, "lof_z": 3.35076722093244, "mis_z": 4.41002630944874, "mu_lof": 8.77492857335e-07, "mu_mis": 9.8858584823e-06, "mu_syn": 3.69967317837e-06, "n_lof": 0.0, "n_mis": 13.0, "n_syn": 44.0, "p_li": 0.97975298984154, "p_null": 1.64821760464209e-05, "p_rec": 0.0202305279824131, "syn_z": -0.354763148858957}, "transcript": "ENST00000481195.1"}, "exons": [{"cdsend": 134206038, "cdsstart": 134197771, "chr": "5", "position": [[134196251, 134197844], [134199085, 134199204], [134200334, 134200496], [134200984, 134201074], [134201847, 134202021], [134205921, 134206131], [134225208, 134225554]], "strand": -1, "transcript": "NM_001355019", "txend": 134225554, "txstart": 134196251}, {"cdsend": 134225861, "cdsstart": 134197771, "chr": "5", "position": [[134194331, 134197844], [134199085, 134199204], [134200334, 134200496], [134200984, 134201074], [134201847, 134202021], [134205921, 134206131], [134225759, 134226073]], "strand": -1, "transcript": "NM_002715", "txend": 134226073, "txstart": 134194331}, {"cdsend": 134225554, "cdsstart": 134225554, "chr": "5", "position": [[134196251, 134197844], [134199085, 134199204], [134200334, 134200507], [134200984, 134201074], [134201847, 134202021], [134205921, 134206131], [134225208, 134225554]], "strand": -1, "transcript": "NR_149151", "txend": 134225554, "txstart": 134196251}], "exons_hg19": [{"cdsend": 133541729, "cdsstart": 133533462, "chr": "5", "position": [[133531942, 133533535], [133534776, 133534895], [133536025, 133536187], [133536675, 133536765], [133537538, 133537712], [133541612, 133541822], [133560899, 133561245]], "strand": -1, "transcript": "NM_001355019", "txend": 133561245, "txstart": 133531942}, {"cdsend": 133561552, "cdsstart": 133533462, "chr": "5", "position": [[133530022, 133533535], [133534776, 133534895], [133536025, 133536187], [133536675, 133536765], [133537538, 133537712], [133541612, 133541822], [133561450, 133561764]], "strand": -1, "transcript": "NM_002715", "txend": 133561764, "txstart": 133530022}, {"cdsend": 133561245, "cdsstart": 133561245, "chr": "5", "position": [[133531942, 133533535], [133534776, 133534895], [133536025, 133536198], [133536675, 133536765], [133537538, 133537712], [133541612, 133541822], [133560899, 133561245]], "strand": -1, "transcript": "NR_149151", "txend": 133561245, "txstart": 133531942}], "generif": [{"pubmed": 11929874, "text": "A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function"}, {"pubmed": 12054646, "text": "regulated by hydrogen peroxide and glutathionylation"}, {"pubmed": 12186863, "text": "role in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils"}, {"pubmed": 12370081, "text": "Results describe the cell cycle expression, subcellular distribution, and metabolic stability of protein phosphatase 2Abeta in comparison with 2Aalpha."}, {"pubmed": 15252037, "text": "the A subunit and alpha-4 (mTap42) require charged residues in separate but overlapping surface regions to associate with the back side of PP2Ac and modulate phosphatase activity"}, {"pubmed": 17693927, "text": "Studies suggest that the target of regulation by PP2A includes upstream kinases in the JNK MAPK pathway."}, {"pubmed": 17803990, "text": "We propose that stabilization of this inactive, nuclear PP2A pool is a major in vivo function of PME-1."}, {"pubmed": 17852432, "text": "down-regulation of expression of PP2A catalytic subunit in CAPE treated cells"}, {"pubmed": 17941990, "text": "PP2Calpha may possess tumor-suppressing properties, and it thereby sets the stage for more elaborate analyses on its involvement in the development and progression of cancer."}, {"pubmed": 18299321, "text": "PP2A functions as a negative regulator in TGF-beta1-induced TAK1 activation"}, {"pubmed": 18430997, "text": "study found that the level of the catalytic subunit of PP2A(PP2Ac) was dramatically decreased in adult Down syndrome brain, and this decrease correlated negatively with tau leveland phosphorylation at several abnormal hyperphosphorylation sites"}, {"pubmed": 18477699, "text": "Aurora-B is an EB1-interacting protein; EB1 stimulates Aurora-B activity through antagonizing its dephosphorylation/inactivation by PP2A"}, {"pubmed": 18583989, "text": "These data shed new light on the significance of negative feedback regulation of NF-kappaB and identifies PP2A as the key regulator of this process."}, {"pubmed": 18586681, "text": "1) PAK plays a required role in hyperosmotic signaling through the PI3K/pTEN/Cdc42/PP2Calpha/p38 pathway, and 2) PAK and PP2Calpha modulate the effects of this pathway on focal adhesion dynamics."}, {"pubmed": 18852266, "text": "PP2A appears to function as an endogenous regulator of SK1 phosphorylation"}, {"pubmed": 18928587, "text": "The activity of PP2A decreases with increasing concentration of arsenic trioxide during the apoptosis of NB4 and MR2 cells."}, {"pubmed": 18949047, "text": "Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A."}, {"pubmed": 18977201, "text": "The catalytic subunit of protein phosphatase 2A (PP2A-C) is the protein interacting with GPR54."}, {"pubmed": 19126401, "text": "The role of PP2A in the phosphorylation of P301L mutant human tau and in neurofibrillary tangle pathology in vivo was determined."}, {"pubmed": 19155497, "text": "The PP2Ac alpha promoter defines a cyclic AMP response element (CRE) site flanked by CpG motifs in human T cells; methylation of the PP2Ac alpha promoter affects CREB binding to the CRE motif and suppresses its activity."}, {"pubmed": 19356149, "text": "study shows that hydrogen peroxide increases the association of PP2A with occludin by a Src kinase-dependent mechanism, and that PP2A activity is involved in hydrogen peroxide-induced disruption of tight junctions in Caco-2 cell monolayers"}, {"pubmed": 19360341, "text": "Expression of tyrosine-phosphorylated PP2A (pY307-PP2A) was highly increased in the HER-2/neu positive breast tumours, and significantly correlated to tumour progression, thus enhancing its potential prognostic value."}, {"pubmed": 19553685, "text": "a new role for mTOR and alpha4/PP2Ac in the control of STAT1 nuclear content, and the expression of interferon-gamma-sensitive genes involved in immunity and apoptosis."}, {"pubmed": 20100830, "text": "VCP/p97-mediated inducible nitric-oxide synthase-dependent Tyr nitration of PP2A increases the levels of phosphatases PP2A and DUSP1 to contribute to the refractory response of conditioned cells"}, {"pubmed": 20106966, "text": "cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3"}, {"pubmed": 20133759, "text": "Data show that HUNK reconstitution in basal breast cancer cell lines prevented protein phosphatase 2-A (PP2A from binding to CFL-1."}, {"pubmed": 20363734, "text": "Neuroprotectin D1 induces dephosphorylation of Bcl-xL in a PP2A-dependent manner during oxidative stress and promotes retinal pigment epithelial cell survival"}, {"pubmed": 20558158, "text": "Silencing of the PP2A/C subunit causes the HER-2/neu positive breast cancer cells to undergo apoptosis via p38 MAPK-related pathways. Phosphorylated Y307-PP2A plays an essential role in cell survival in these cells."}, {"pubmed": 20615878, "text": "Cross-talk between serine/threonine protein phosphatase 2A and protein tyrosine phosphatase 1B regulates Src activation and adhesion of integrin alphaIIbbeta3 to fibrinogen."}, {"pubmed": 20663872, "text": "identification of a PP2A trimeric holoenzyme containing B55alpha, which plays a major role in restricting the phosphorylation state of p107 and inducing its activation in human cells."}, {"pubmed": 20677014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20711181, "text": "Results demonstrate that PP2A-B55alpha and importin-beta1 cooperate in the regulation of postmitotic assembly mechanisms in human cells."}, {"pubmed": 21072166, "text": "Data show that the I84P mutation or the IIQ/VTR(83-85) and T89A substitutions in the Vpr(77-92) sequence prevent PP2A(1) binding."}, {"pubmed": 21151953, "text": "protein serine/threonine phosphatase PP2Calpha activation efficiently prevents liver fibrosis"}, {"pubmed": 21172653, "text": "The recruitment of PP2A to UNC5H2/B allows the activation of DAPk via a PP2A-mediated dephosphorylation and that this mechanism is involved in angiogenesis regulation."}, {"pubmed": 21346232, "text": "PP2Acalpha represents a new methylation-sensitive gene that contributes to the pathogenesis of systemic lupus erythematosus."}, {"pubmed": 21355954, "text": "Protein phosphatase 2A was not associated with carcinoma progression of lung neoplasms."}, {"pubmed": 21393425, "text": "modulation of PP2A activity may represent an alternative therapeutic approach for the treatment of advanced androgen-independent prostate cancer."}, {"pubmed": 21454489, "text": "both the C-terminal Mid1-binding domain and the PP2Ac-binding determinants are required for Alpha4-mediated protection of PP2Ac from polyubiquitination and degradation."}, {"pubmed": 21590681, "text": "evidence of an association between PPP2CA polymorphisms and elevated PP2Ac transcript levels in T cells, which implicates a new molecular pathway for systemic lupus erythematosus susceptibility in European Americans, Hispanic Americans, and Asians."}, {"pubmed": 21791414, "text": "Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A."}, {"pubmed": 21835928, "text": "dephosphorylation of pS776-ATXN1 by PP2A regulates the interaction of ATXN1 with the splicing factors RBM17 and U2AF65"}, {"pubmed": 21959857, "text": "The PP2A activity was unchanged in failing hearts despite an increase of both total PP and PP1 activity."}, {"pubmed": 21996587, "text": "Deletion of residue Cys269 alters the conformation and activity of PP2A(D) and influences the interaction between PP2A and various metal ions, notably Mn(2+)."}, {"pubmed": 22031698, "text": "analysis of resistance of Akt kinase and PP2A to dephosphorylation through ATP-dependent conformational plasticity"}, {"pubmed": 22135143, "text": "The results show that a low-dose treatment of MCLR in FL cells for 6 h induced an increase in PP2A activity, and a high-dose treatment of MCLR for 24 h decreased the activity of PP2A, as expected."}, {"pubmed": 22167190, "text": "Identification and characterization of an alternatively spliced isoform of the human protein phosphatase 2Aalpha catalytic subunit."}, {"pubmed": 22192750, "text": "A biological strategy, used by various viruses based on the targeting of PP2A enzymes by viral proteins, in order to specifically deregulate cellular pathways of their hosts."}, {"pubmed": 22299668, "text": "Studies indicate that the Ser/Thr phosphatases PP1 and PP2A are responsible for the dephosphorylation and activation of Rb proteins."}, {"pubmed": 22314363, "text": "EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex"}, {"pubmed": 22443683, "text": "Data indicate that PP2A holoenzyme biogenesis and activity are controlled by five PP2A modulators, consisting of alpha4, PTPA, LCMT1, PME-1 and TIPRL1, which serve to prevent promiscuous phosphatase activity until the holoenzyme is completely assembled."}, {"pubmed": 22479341, "text": "Data show that knockdown of the catalytic subunit of PP1 (PP1Calpha), but not PP2A (PP2ACalpha), increased pS137-PFN1 levels."}, {"pubmed": 22685328, "text": "Semaphorin 3A impinged upon the basal activity of the serine phosphatase PP2A and disrupted PP2A interaction with VE-cadherin, leading to cell-cell junction disorganization and increased permeability."}, {"pubmed": 22732552, "text": "GSK-3beta can inhibit PP2A by increasing the inhibitory L309-demethylation involving upregulation of PME-1 and inhibition of PPMT1"}, {"pubmed": 22904676, "text": "disruption of PP2Ac methylation may contribute to cancer, and modulation of this methylation may serve as an anticancer target."}, {"pubmed": 22961627, "text": "Together, these observations suggest that PP2A regulates hTERT subcellular localization, in addition to its inhibitory effects on telomerase activity"}, {"pubmed": 23064762, "text": "These results demonstrate that acetaldehyde-induced disruption of tight junctions is mediated by PP2A translocation to tight junctions and dephosphorylation of occludin on threonine residues."}, {"pubmed": 23183242, "text": "Data suggest that inhibition of PPP2CA activity impairs osteoclastogenesis by regulating RANKL (receptor activator of nuclear factor-kappa B ligand) and OPG (osteoprotegerin) expression in osteoblasts."}, {"pubmed": 23184344, "text": "Inhibition of PP2A by okadaic acid curtailed the free fatty acids induced upregulation of SREBP1 expression, fatty acid synthase promoter transcriptional activity and lipid accumulation in HepG2 cells"}, {"pubmed": 23185379, "text": "activation of PP2A or inactivation of the p38MAPK-MAPKAPK2-Hsp27 has a role in survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity"}, {"pubmed": 23290789, "text": "Results suggest that Tgase-2/PP2A/JNK might be a novel axis that affects N-cadherin switching in the epithelial-mesenchymal-transition (EMT) of A549 lung cancer cells."}, {"pubmed": 23434594, "text": "SPRY2, PTEN, and PP2A status is an important determinant of prostate cancer progression."}, {"pubmed": 23651848, "text": "Our data reveal a protective role of TWEAK in glucose homeostasis and identify PP2A as a new driver in the modulation of TNF-alpha signaling by sTWEAK."}, {"pubmed": 23677989, "text": "Results reveal that nilotinib induces the autophagy-inducing activity is associated with PP2A-regulated AMPK phosphorylation."}, {"pubmed": 23720779, "text": "Data indicate that XIAP E3 ligase mediates cyclin D1 transcription via PP2A-regulated c-Jun/AP-1 activation."}, {"pubmed": 23775084, "text": "Data suggest that enhanced PP2Ac in systemic lupus erythematosus (SLE) T-cells may dephosphorylate and activate the signaling pathway upstream of DNMT1, thus disturbing the tight control of methylation-sensitive genes involved in SLE pathogenesis."}, {"pubmed": 23892082, "text": "Unlike yeast TIP41, TIPRL has a positive effect on mTORC1 signaling through the association with PP2Ac."}, {"pubmed": 23901063, "text": "PP2Ac is upregulated in tumorous liver biopsies and negatively correlated with p53 proapoptotic gene expression."}, {"pubmed": 24054836, "text": "Reduced expression of PP2A/PR65 in ameloblastoma compared with normal oral mucosa indicates that PP2A/PR65 is involved in the occurrence and development of ameloblastoma."}, {"pubmed": 24064353, "text": "PP2A holoenzyme and PP6 were found stably associated with U1 snRNP; findings indicate that these phosphatases regulate splicing catalysis involving U1 snRNP and suggest an important evolutionary conserved role of PP2A family phosphatases in pre-mRNA splicing"}, {"pubmed": 24100030, "text": "a novel mechanism by which the interaction between PP2A and Src in the context of caspase-8 activation modulates TRAIL sensitivity in cancer cells."}, {"pubmed": 24145130, "text": "the alpha4 N-terminus binding to endogenous PP2Ac and PABP, and the C-terminus to EDD, is reported."}, {"pubmed": 24269630, "text": "Activation of BAFF-mediated PP2A-Erk1/2 pathway and B-cell proliferation is dependent upon the intracellular divalent Ca2+-ion."}, {"pubmed": 24382322, "text": "Data indicate that TCDD or omeprazole caused protein phosphatase 2A (PP2A)-mediated dephosphorylation of Sp1 transcription factor at Ser-59 and induced CYP1A1 transcription."}, {"pubmed": 24462681, "text": "PP2A constitutively dephosphorylates dCK in cells and negatively regulates its activity."}, {"pubmed": 24550388, "text": "This result combined with a number of biophysical analyses provide evidence that the coiled coil domain of striatin 3 and the PP2A A subunit form a stable core complex with a 2:2 stoichiometry"}, {"pubmed": 24621013, "text": "Findings suggest the possible contribution of SET protein to the tumor progression and the utility of protein phosphatase 2A (PP2A) activator, FTY720 for treatment of alveolar soft part sarcoma (ASPS)."}, {"pubmed": 24642616, "text": "Our findings suggest that PPP2CA downregulation serves as a molecular link between gain of castration-resistance and aggressive PCa phenotype, and its restoration could be an effective preventive/therapeutic approach against the advanced disease."}, {"pubmed": 24696731, "text": "These results suggest that the aberrant expression of PP2A in human clear cell renal cell carcinoma"}, {"pubmed": 24770487, "text": "PPP2AC activity is required for SREBP-2 DNA binding."}, {"pubmed": 24841198, "text": "this study suggests that the tightly linked regulatory loop comprised of the SIK2-PP2A and CaMKI and PME-1 networks may function in fine-tuning cell proliferation and stress response."}, {"pubmed": 24958351, "text": "decreased eEF2 phosphorylation, mediated by increased PP2A activity, contributes to resistance to HER2 inhibition and may provide novel targets for therapeutic intervention in HER2 positive breast cancer which is resistant to HER2 targeted therapies."}, {"pubmed": 25003662, "text": "Phosphorylated PP2A is an alteration that determines poor outcome in metastatic colorectal cancer."}, {"pubmed": 25015035, "text": "Studies indicate that oncoprotein CIP2A (KIAA1524) controls oncogenic cellular signals by suppressing protein phosphatase 2A (PP2A)."}, {"pubmed": 25152517, "text": "Data suggest that expression of PP2A (protein phosphatase 2 catalytic subunit alpha) and PTEN (phosphatase and tensin homolog) is down-regulated in adenomyosis as compared to normal endometrium; expression of survivin appears to be up-regulated."}, {"pubmed": 25207814, "text": "MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac in X-linked Opitz syndrome."}, {"pubmed": 25219467, "text": "GSK-3b and PP2A regulate each other and control tau phosphorylation both directly and indirectly through each other."}, {"pubmed": 25253569, "text": "possible role of an miR-155-PP2Ac loop in regulating IL-2 release"}, {"pubmed": 25567480, "text": "Increased PP2A activity and reduced phosphorylation of PP2A were observed in alpha-synuclein overexpression primary cortex neurons."}, {"pubmed": 25612003, "text": "Idiopathic pulmonary fibrosis fibroblast interaction with polymerized type I collagen results in an aberrant PP2A/HDAC4 axis, which suppresses miR-29, causing a pathologic increase in type I collagen expression."}, {"pubmed": 25645927, "text": "HSP105 depletion disrupts the integration of protein phosphatase 2A into the beta-catenin degradation complex, favoring the hyperphosphorylation and degradation of beta-catenin."}, {"pubmed": 25708299, "text": "Mutations in the structurally buried D38 residue of PP2Calpha (PPM1A) redefined the water-mediated hydrogen network in the active site and selectively disrupted M2 metal ion binding."}, {"pubmed": 25939762, "text": "Data indicate that LB100 attenuates protein phosphatase 2A (PP2A) activity alone and following radiation."}, {"pubmed": 25945834, "text": "Data show that the biogical effect of inhibitor-2 of protein phosphatase-2A (SET) on proliferation and invasion was mediated by the inhibition of the protein phosphatase 2A (PP2A)."}, {"pubmed": 25956027, "text": "Binding of calmodulin changes the calcineurin regulatory region to a less dynamic conformation."}, {"pubmed": 25979969, "text": "Data suggest that activation of TAZ (tafazzin) inhibits adipogenesis in mesenchymal stem cells; interaction of TAZ and protein phosphatases (PP1A, PP2A) up-regulates dephosphorylation and transport of TAZ to cell nucleus."}, {"pubmed": 26053095, "text": "Data show that the protein phosphatase 2A (PP2A)/c-jun N-Terminal Kinase (JNK)/Sp1 transcription factor/CDK1 kinase pathway and the autophagy/cyclin kinase inhibitor p21 pathway participated in G2/M cell cycle arrest triggered by PP2A inhibitors."}, {"pubmed": 26234767, "text": "Alterations affecting PP2A subunits together with the deregulation of endogenous PP2A inhibitors such as CIP2A and SET have been described as contributing mechanisms to inactivate PP2A in prostate cancer."}, {"pubmed": 26310906, "text": "Concurrent mTORC1 inactivation and PP2A-B55alpha stimulation fuel ULK1-dependent autophagy."}, {"pubmed": 26378614, "text": "that loss of glucocerebrosidase function may contribute to SNCA accumulation through inhibition of autophagy via PPP2A inactivation"}, {"pubmed": 26563471, "text": "Data suggest a critical role for the I2PP2A protein (SET)-protein phosphatase-2A (PP2A) signaling axis in Pten protein (Pten) deficient castration resistant prostate cancer (CRPC) progression."}, {"pubmed": 26575017, "text": "Data show that downregulating proto-oncogene protein Akt (p-Akt) by inhibiting PP2A inhibitor SET-mediated protein phosphatase 2A (PP2A) inactivation determined the pro-apoptotic effects of EMQA and paclitaxel combination treatment."}, {"pubmed": 26592247, "text": "Both PP-1 and PP-2A are directly involved in regulating eye development, and are aberrantly expressed in cataract and glaucoma patients. (Review)"}, {"pubmed": 26618405, "text": "PP2Ac upregulation has a poor prognostic impact on the overall survival of hepatocellular carcinoma (HCC) patients and contributes to the aggressiveness of HCC. PP2Ac may represent a potential therapeutic target for HCC."}, {"pubmed": 26876307, "text": "Data show that loss of epithelial membrane protein 2 (EMP2) is involved in sphingosylphosphorylcholine (SPC)-induced phosphorylation of keratin 8 (K8) via ubiquitination of protein phosphatase 2 (PP2A) through alpha4 phosphoprotein by caveolin-1 (cav-1)."}, {"pubmed": 27169767, "text": "Knockdown of Alpha4 preferentially impacts the expression of PP4c and PP6c compared to expression levels of PP2Ac."}, {"pubmed": 27306323, "text": "Suspension survival mediated by PP2A-STAT3-Col XVII determines tumor initiation and metastasis in cancer stem cells."}, {"pubmed": 27334924, "text": "these data support a role for the novel PP2Ac-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity."}, {"pubmed": 27517624, "text": "Results show that miR-199b is a tumor suppressor emerges as a potential contributing mechanism to inhibit PP2A via PP2A inhibitor SET (SET) overexpression in metastatic colorectal cancer (mCRC)."}, {"pubmed": 27531894, "text": "B55alpha-PP2A mutations in acute myeloid leukemia have roles in leukemogenesis by promoting AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest"}, {"pubmed": 27600565, "text": "This work has significantly advanced our understanding of the RACK1/PP2A complex and suggests a pro-carcinogenic role for the RACK1/PP2A interaction. This work suggests that approaches to target the RACK1/PP2A complex are a viable option to regulate PP2A activity and identifies a novel potential therapeutic target in the treatment of breast cancer."}, {"pubmed": 27611305, "text": "RAB9 competes with the catalytic subunit PPP2CA in binding to PPP2R1A. This competitive association has an important role in controlling the PP2A catalytic activity."}, {"pubmed": 27612201, "text": "protein phosphatase 2A (PP2A)-mediated Raf-MEK-ERK signaling was involved in glutaminolysis in endothelial cells."}, {"pubmed": 27696687, "text": "Binding of PP2A and Akt increased in response to cAMP or phosphatidic acid (PA), suggesting that their binding is directly responsible for the inactivation of Akt during decidualization."}, {"pubmed": 27913678, "text": "Studies indicate that protein phosphatase methylesterase-1 (PME-1) negatively regulates protein phosphatase 2A (PP2A) activity by highly complex mechanisms."}, {"pubmed": 28144936, "text": "The results showed SNPs near PPP2CA were associated with decreased expression of PPP2CA mRNA in PBMCs from patients with SLE and suggested that the mRNA expression of the gene may be correlated with the pathogenesis of SLE."}, {"pubmed": 28904398, "text": "These findings support our hypothesis that genetic variants in PPP2CA may be implicated in gastric cancer susceptibility in Chinese population."}, {"pubmed": 29066346, "text": "Moreover, PP2Acalpha2-overexpressed cells demonstrated increased expression of IGBP1, activated mTORC1 signaling to reduce basal autophagy and increased anchorage-independent growth. Our study provides new insights into the complex mechanisms of PP2A regulation."}, {"pubmed": 29450633, "text": "Data show that protein phosphatase-2A (PP2A) was upregulated in lung adenocarcinoma cell lines that were transfected with midline 1 E3 ubiquitin-protein ligase (MID1)-siRNA, suggesting MID1 negatively regulates PP2A in lung adenocarcinoma."}, {"pubmed": 29979448, "text": "This study demonstrated an association of PPP2CA (rs10491322 and rs7704116) with systemic lupus erythematosus susceptibility in a Chinese Han population. Furthermore, the minor allele of PPP2CA rs10491322 as a risk factor was correlated with immunologic disorders for systemic lupus erythematosus."}, {"pubmed": 29996119, "text": "alpha-Syn bound to PP2A Calpha by the hydrophobic interaction and upregulated its activity. Blocking the hydrophobic domain of alpha-Syn or hydrophilic mutation on the residue I123 in PP2A Calpha all reduced PP2A activity upregulation by alpha-Syn."}, {"pubmed": 30275201, "text": "High PP2A expression is associated with Colorectal Cancer Cell Invasiveness."}, {"pubmed": 30296597, "text": "PPP2CA may act as an oncogene in the progression of colorectal cancer"}, {"pubmed": 30453012, "text": "the phosphorylation levels of several substrates of PP2A, namely Akt, S6 kinase, and GSK3beta, were decreased in CLN8 disease patient fibroblasts."}, {"pubmed": 30595372, "text": "pathogenic PPP2CA variants impair PP2A-B56(delta) functionality, suggesting that PP2A-related neurodevelopmental disorders constitute functionally converging intellectual disability syndromes"}, {"pubmed": 30679389, "text": "These data demonstrate that LB-100 is a catalytic inhibitor of both PP2AC and PPP5C and suggest that the observed antitumor activity might be due to an additive effect achieved by suppressing both PP2A and PPP5C."}, {"pubmed": 30684253, "text": "P2ACalpha negatively regulates LPS-induced cytokine secretion of Alveolar macrophages by NF-kappaB and MAPK pathways. Together, these findings provide the evidence to guide the development of novel therapeutic options targeting PP2ACalpha for Acute respiratory distress syndrome/acute lung injury."}, {"pubmed": 30927143, "text": "These results suggest that miR-650/PPP2CA axis could be modulated to interfere with motile ability of thyroid carcinoma cells"}, {"pubmed": 30943283, "text": "High PP2A expression is associated with diffuse intrinsic pontine gliomas."}, {"pubmed": 31164634, "text": "Hydrogen peroxide (H2O2) inhibits protein phosphatase 2 A activity during mitosis."}, {"pubmed": 31461344, "text": "Ca2+-activated Cl- channels encoded by the Tmem16a gene are regulated by calmodulin-dependent protein kinase II (CaMKII) and protein phosphatases 1 (PP1) and 2A (PP2A)."}, {"pubmed": 31605257, "text": "PP2A is involved in apoptotic induction of hepatocytes after brain death by specific suppression of Akt."}, {"pubmed": 31992581, "text": "Antibodies recognizing the C terminus of PP2A catalytic subunit are unsuitable for evaluating PP2A activity and holoenzyme composition."}, {"pubmed": 32123010, "text": "AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A Inactivation."}, {"pubmed": 32681005, "text": "Dissecting the sequence determinants for dephosphorylation by the catalytic subunits of phosphatases PP1 and PP2A."}, {"pubmed": 32900880, "text": "Quantitative kinase and phosphatase profiling reveal that CDK1 phosphorylates PP2Ac to promote mitotic entry."}, {"pubmed": 32966759, "text": "Integrator Recruits Protein Phosphatase 2A to Prevent Pause Release and Facilitate Transcription Termination."}, {"pubmed": 33128264, "text": "SIK2 represses AKT/GSK3beta/beta-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases."}, {"pubmed": 33184242, "text": "High-glucose-induced apoptosis, ROS production and pro-inflammatory response in cardiomyocytes is attenuated by metformin treatment via PP2A activation."}, {"pubmed": 34100859, "text": "Evolutionary crossroads of cell signaling: PP1 and PP2A substrate sites in intrinsically disordered regions."}, {"pubmed": 34425033, "text": "PP-1beta and PP-2Aalpha modulate cAMP response element-binding protein (CREB) functions in aging control and stress response through de-regulation of alphaB-crystallin gene and p300-p53 signaling axis."}, {"pubmed": 34485508, "text": "Inhibiting PP2Acalpha Promotes the Malignant Phenotype of Gastric Cancer Cells through the ATM/METTL3 Axis."}, {"pubmed": 34502355, "text": "Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice."}, {"pubmed": 34521817, "text": "Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation."}, {"pubmed": 34780974, "text": "PP2A Catalytic Subunit alpha promotes fibroblast activation and kidney fibrosis via ERK pathway."}, {"pubmed": 34902541, "text": "Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities."}, {"pubmed": 34922339, "text": "The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells."}, {"pubmed": 35643235, "text": "Liver PP2A-Calpha Protects From Parenteral Nutrition-associated Hepatic Steatosis."}, {"pubmed": 36555359, "text": "The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors."}, {"pubmed": 37219874, "text": "PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma."}, {"pubmed": 38637456, "text": "PPP2CA Inhibition Promotes Ferroptosis Sensitivity Through AMPK/SCD1 Pathway in Colorectal Cancer."}], "genomic_pos": {"chr": "5", "end": 134226073, "ensemblgene": "ENSG00000113575", "start": 134194035, "strand": -1}, "genomic_pos_hg19": {"chr": "5", "end": 133561833, "start": 133530025, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000278", "qualifier": "involved_in", "term": "mitotic cell cycle"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0001932", "pubmed": 28386764, "qualifier": "involved_in", "term": "regulation of protein phosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006470", "pubmed": 33108758, "qualifier": "involved_in", "term": "protein dephosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006470", "pubmed": 2849764, "qualifier": "involved_in", "term": "protein dephosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007498", "qualifier": "involved_in", "term": "mesoderm development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010288", "qualifier": "involved_in", "term": "response to lead ion"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0010288", "pubmed": 22387731, "qualifier": "involved_in", "term": "response to lead ion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010719", "pubmed": 20080667, "qualifier": "involved_in", "term": "negative regulation of epithelial to mesenchymal transition"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035331", "pubmed": 33633399, "qualifier": "involved_in", "term": "negative regulation of hippo signaling"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0035556", "pubmed": 11007961, "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035970", "pubmed": 30611118, "qualifier": "involved_in", "term": "peptidyl-threonine dephosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035970", "pubmed": 15525651, "qualifier": "involved_in", "term": "peptidyl-threonine dephosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0035970", "pubmed": 16262633, "qualifier": "involved_in", "term": "peptidyl-threonine dephosphorylation"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0040008", "pubmed": 11360189, "qualifier": "involved_in", "term": "regulation of growth"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043029", "qualifier": "involved_in", "term": "T cell homeostasis"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0045595", "pubmed": 11360189, "qualifier": "involved_in", "term": "regulation of cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051321", "qualifier": "involved_in", "term": "meiotic cell cycle"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051898", "pubmed": 21806946, "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051898", "qualifier": "involved_in", "term": "negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0070262", "pubmed": 16262633, "qualifier": "involved_in", "term": "peptidyl-serine dephosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071902", "pubmed": 20080667, "qualifier": "involved_in", "term": "positive regulation of protein serine/threonine kinase activity"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1900227", "qualifier": "involved_in", "term": "positive regulation of NLRP3 inflammasome complex assembly"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:1904526", "pubmed": 28386764, "qualifier": "involved_in", "term": "regulation of microtubule binding"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1904528", "qualifier": "involved_in", "term": "positive regulation of microtubule binding"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1904539", "qualifier": "involved_in", "term": "negative regulation of glycolytic process through fructose-6-phosphate"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000045", "pubmed": 25438055, "qualifier": "involved_in", "term": "regulation of G1/S transition of mitotic cell cycle"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000159", "pubmed": [17055435, 17174897], "qualifier": "part_of", "term": "protein phosphatase type 2A complex"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0000159", "pubmed": 11007961, "qualifier": "part_of", "term": "protein phosphatase type 2A complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0000775", "qualifier": "located_in", "term": "chromosome, centromeric region"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0000922", "qualifier": "located_in", "term": "spindle pole"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 11007961, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0005739", "pubmed": 11007961, "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "pubmed": 11007961, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0008287", "pubmed": 29063833, "qualifier": "part_of", "term": "protein serine/threonine phosphatase complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0015630", "pubmed": 11007961, "qualifier": "located_in", "term": "microtubule cytoskeleton"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 11007961, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045121", "pubmed": 16258073, "qualifier": "located_in", "term": "membrane raft"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0045202", "qualifier": "located_in", "term": "synapse"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 20458337, "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0090443", "pubmed": [29063833, 33633399], "qualifier": "part_of", "term": "FAR/SIN/STRIPAK complex"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004721", "pubmed": 28386764, "qualifier": "enables", "term": "phosphoprotein phosphatase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004722", "qualifier": "enables", "term": "protein serine/threonine phosphatase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004722", "pubmed": [25438055, 30513302, 30595372, 30611118], "qualifier": "enables", "term": "protein serine/threonine phosphatase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004722", "qualifier": "enables", "term": "protein serine/threonine phosphatase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004722", "pubmed": [10640627, 16262633, 21131359, 28386764], "qualifier": "enables", "term": "protein serine/threonine phosphatase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004725", "pubmed": 15525651, "qualifier": "enables", "term": "protein tyrosine phosphatase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [1328865, 7592815, 8392071, 8617797, 9647778, 11591705, 11839802, 12963337, 15467457, 15761952, 16044149, 16085932, 16126728, 16129692, 16189514, 16239230, 16258073, 16456541, 16541025, 16580887, 16764867, 17055435, 17245430, 17274953, 17384681, 17485487, 17529992, 17540176, 17974561, 18394995, 18715871, 18716626, 18782753, 18977201, 19060904, 19156129, 19293187, 19915589, 20080667, 20927323, 21460856, 21806989, 21988832, 23892082, 24126060, 25531779, 26256536, 26496610, 27588481, 27880917, 28330616, 28609714, 30595372, 30611118, 32296183, 32814053, 32878885, 33633399, 37761890], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0017018", "qualifier": "enables", "term": "myosin phosphatase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0046982", "pubmed": 9847399, "qualifier": "enables", "term": "protein heterodimerization activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0048156", "pubmed": 28386764, "qualifier": "enables", "term": "tau protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0050811", "qualifier": "enables", "term": "GABA receptor binding"}]}, "homologene": {"genes": [[3702, 837583], [3702, 842276], [3702, 843333], [4530, 4328734], [4530, 4341364], [4896, 2542052], [6239, 178117], [7165, 1279592], [7227, 45959], [7955, 393885], [8364, 394888], [9031, 416318], [9598, 471633], [9606, 5515], [9615, 403608], [9913, 282320], [10090, 19052], [10116, 24672]], "id": 37660}, "interpro": [{"desc": "Calcineurin-like phosphoesterase domain, ApaH type", "id": "IPR004843", "short_desc": "Calcineurin-like_PHP_ApaH"}, {"desc": "Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase", "id": "IPR006186", "short_desc": "Ser/Thr-sp_prot-phosphatase"}, {"desc": "Metallo-dependent phosphatase-like", "id": "IPR029052", "short_desc": "Metallo-depent_PP-like"}, {"desc": "Serine/Threonine protein phosphatase PP2A-like", "id": "IPR047129", "short_desc": "PPA2-like"}], "ipi": ["IPI00008380", "IPI00976419", "IPI00984991"], "map_location": "5q31.1", "name": "protein phosphatase 2 catalytic subunit alpha", "other_names": ["PP2A-alpha", "protein phosphatase 2, catalytic subunit, alpha isozyme", "replication protein C", "serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform"], "pantherdb": {"HGNC": "9299", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1321159", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 10090, "uniprot_kb": "P63330"}, {"Ensembl": "ENSRNOG00000001893", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 10116, "uniprot_kb": "A0A0G2JYA4"}, {"RGD": "3380", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 10116, "uniprot_kb": "P63331"}, {"Ensembl": "ENSGALG00000006462", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 9031, "uniprot_kb": "Q5ZM47"}, {"ZFIN": "ZDB-GENE-050417-441", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 7955, "uniprot_kb": "Q567Y8"}, {"ZFIN": "ZDB-GENE-040426-877", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 7955, "uniprot_kb": "F1Q6Z7"}, {"WormBase": "WBGene00002363", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 6239, "uniprot_kb": "G5EGK8"}, {"FlyBase": "FBgn0004177", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 7227, "uniprot_kb": "P23696"}, {"SGD": "S000002347", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 4932, "uniprot_kb": "P23595"}, {"SGD": "S000002292", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 4932, "uniprot_kb": "P23594"}, {"PomBase": "SPAC823.15", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 4896, "uniprot_kb": "P23635"}, {"PomBase": "SPBC16H5.07c", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 4896, "uniprot_kb": "P23636"}, {"dictyBase": "DDB_G0290263", "ortholog_type": "LDO", "panther_family": "PTHR45619", "taxid": 352472, "uniprot_kb": "Q9XZE5"}, {"TAIR": "2020598", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 3702, "uniprot_kb": "O04951"}, {"TAIR": "2025976", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 3702, "uniprot_kb": "Q07099"}, {"TAIR": "2194626", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 3702, "uniprot_kb": "Q07098"}, {"TAIR": "2041579", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 3702, "uniprot_kb": "Q07100"}, {"TAIR": "2076451", "ortholog_type": "O", "panther_family": "PTHR45619", "taxid": 3702, "uniprot_kb": "P48578"}], "uniprot_kb": "P67775"}, "pathway": {"biocarta": [{"id": "aktpathway", "name": "akt signaling pathway"}, {"id": "eif4pathway", "name": "regulation of eif-4e and p70s6 kinase"}], "kegg": [{"id": "hsa03015", "name": "mRNA surveillance pathway - Homo sapiens (human)"}, {"id": "hsa04071", "name": "Sphingolipid signaling pathway - Homo sapiens (human)"}, {"id": "hsa04114", "name": "Oocyte meiosis - Homo sapiens (human)"}, {"id": "hsa04136", "name": "Autophagy - other - Homo sapiens (human)"}, {"id": "hsa04140", "name": "Autophagy - animal - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04152", "name": "AMPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa04261", "name": "Adrenergic signaling in cardiomyocytes - Homo sapiens (human)"}, {"id": "hsa04350", "name": "TGF-beta signaling pathway - Homo sapiens (human)"}, {"id": "hsa04390", "name": "Hippo signaling pathway - Homo sapiens (human)"}, {"id": "hsa04530", "name": "Tight junction - Homo sapiens (human)"}, {"id": "hsa04728", "name": "Dopaminergic synapse - Homo sapiens (human)"}, {"id": "hsa04730", "name": "Long-term depression - Homo sapiens (human)"}, {"id": "hsa05142", "name": "Chagas disease - Homo sapiens (human)"}, {"id": "hsa05160", "name": "Hepatitis C - Homo sapiens (human)"}, {"id": "hsa05165", "name": "Human papillomavirus infection - Homo sapiens (human)"}], "netpath": [{"id": "Pathway_IL3", "name": "IL3"}, {"id": "Pathway_Wnt", "name": "Wnt"}], "pid": [{"id": "atr_pathway", "name": "ATR signaling pathway"}, {"id": "erbb1_downstream_pathway", "name": "ErbB1 downstream signaling"}, {"id": "il8cxcr2_pathway", "name": "IL8- and CXCR2-mediated signaling events"}, {"id": "myc_pathway", "name": "C-MYC pathway"}, {"id": "p53regulationpathway", "name": "p53 pathway"}, {"id": "pdgfrbpathway", "name": "PDGFR-beta signaling pathway"}, {"id": "plk1_pathway", "name": "PLK1 signaling events"}, {"id": "rb_1pathway", "name": "Regulation of retinoblastoma protein"}, {"id": "tgfbrpathway", "name": "TGF-beta receptor signaling"}], "reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-111885", "name": "Opioid Signalling"}, {"id": "R-HSA-113501", "name": "Inhibition of replication initiation of damaged DNA by RB1/E2F1"}, {"id": "R-HSA-113510", "name": "E2F mediated regulation of DNA replication"}, {"id": "R-HSA-1169410", "name": "Antiviral mechanism by IFN-stimulated genes"}, {"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-1295596", "name": "Spry regulation of FGF signaling"}, {"id": "R-HSA-141424", "name": "Amplification of signal from the kinetochores"}, {"id": "R-HSA-141444", "name": "Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-163685", "name": "Integration of energy metabolism"}, {"id": "R-HSA-163767", "name": "PP2A-mediated dephosphorylation of key metabolic factors"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-166016", "name": "Toll Like Receptor 4 (TLR4) Cascade"}, {"id": "R-HSA-166058", "name": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane"}, {"id": "R-HSA-166166", "name": "MyD88-independent TLR4 cascade "}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-168138", "name": "Toll Like Receptor 9 (TLR9) Cascade"}, {"id": "R-HSA-168142", "name": "Toll Like Receptor 10 (TLR10) Cascade"}, {"id": "R-HSA-168164", "name": "Toll Like Receptor 3 (TLR3) Cascade"}, {"id": "R-HSA-168176", "name": "Toll Like Receptor 5 (TLR5) Cascade"}, {"id": "R-HSA-168179", "name": "Toll Like Receptor TLR1:TLR2 Cascade"}, {"id": "R-HSA-168181", "name": "Toll Like Receptor 7/8 (TLR7/8) Cascade"}, {"id": "R-HSA-168188", "name": "Toll Like Receptor TLR6:TLR2 Cascade"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168898", "name": "Toll-like Receptor Cascades"}, {"id": "R-HSA-180024", "name": "DARPP-32 events"}, {"id": "R-HSA-181438", "name": "Toll Like Receptor 2 (TLR2) Cascade"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-190236", "name": "Signaling by FGFR"}, {"id": "R-HSA-194315", "name": "Signaling by Rho GTPases"}, {"id": "R-HSA-195253", "name": "Degradation of beta-catenin by the destruction complex"}, {"id": "R-HSA-195258", "name": "RHO GTPase Effectors"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-196299", "name": "Beta-catenin phosphorylation cascade"}, {"id": "R-HSA-198725", "name": "Nuclear Events (kinase and transcription factor activation)"}, {"id": "R-HSA-198753", "name": "ERK/MAPK targets"}, {"id": "R-HSA-199418", "name": "Negative regulation of the PI3K/AKT network"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-202670", "name": "ERKs are inactivated"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2465910", "name": "MASTL Facilitates Mitotic Progression"}, {"id": "R-HSA-2467813", "name": "Separation of Sister Chromatids"}, {"id": "R-HSA-2500257", "name": "Resolution of Sister Chromatid Cohesion"}, {"id": "R-HSA-2555396", "name": "Mitotic Metaphase and Anaphase"}, {"id": "R-HSA-2995383", "name": "Initiation of Nuclear Envelope (NE) Reformation"}, {"id": "R-HSA-2995410", "name": "Nuclear Envelope (NE) Reassembly"}, {"id": "R-HSA-3700989", "name": "Transcriptional Regulation by TP53"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-388841", "name": "Costimulation by the CD28 family"}, {"id": "R-HSA-389513", "name": "CTLA4 inhibitory signaling"}, {"id": "R-HSA-418346", "name": "Platelet homeostasis"}, {"id": "R-HSA-418594", "name": "G alpha (i) signalling events"}, {"id": "R-HSA-432142", "name": "Platelet sensitization by LDL"}, {"id": "R-HSA-448424", "name": "Interleukin-17 signaling"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-450282", "name": "MAPK targets/ Nuclear events mediated by MAP kinases"}, {"id": "R-HSA-450294", "name": "MAP kinase activation"}, {"id": "R-HSA-453274", "name": "Mitotic G2-G2/M phases"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-4641262", "name": "Disassembly of the destruction complex and recruitment of AXIN to the membrane"}, {"id": "R-HSA-4641262", "name": "Disassembly of the destruction complex and recruitment of AXIN to the membrane"}, {"id": "R-HSA-4791275", "name": "Signaling by WNT in cancer"}, {"id": "R-HSA-4839735", "name": "Signaling by AXIN mutants"}, {"id": "R-HSA-4839743", "name": "Signaling by CTNNB1 phospho-site mutants"}, {"id": "R-HSA-4839744", "name": "Signaling by APC mutants"}, {"id": "R-HSA-4839748", "name": "Signaling by AMER1 mutants"}, {"id": "R-HSA-5339716", "name": "Signaling by GSK3beta mutants"}, {"id": "R-HSA-5358747", "name": "CTNNB1 S33 mutants aren't phosphorylated"}, {"id": "R-HSA-5358749", "name": "CTNNB1 S37 mutants aren't phosphorylated"}, {"id": "R-HSA-5358751", "name": "CTNNB1 S45 mutants aren't phosphorylated"}, {"id": "R-HSA-5358752", "name": "CTNNB1 T41 mutants aren't phosphorylated"}, {"id": "R-HSA-5467337", "name": "APC truncation mutants have impaired AXIN binding"}, {"id": "R-HSA-5467340", "name": "AXIN missense mutants destabilize the destruction complex"}, {"id": "R-HSA-5467348", "name": "Truncations of AMER1 destabilize the destruction complex"}, {"id": "R-HSA-5633007", "name": "Regulation of TP53 Activity"}, {"id": "R-HSA-5654726", "name": "Negative regulation of FGFR1 signaling"}, {"id": "R-HSA-5654727", "name": "Negative regulation of FGFR2 signaling"}, {"id": "R-HSA-5654732", "name": "Negative regulation of FGFR3 signaling"}, {"id": "R-HSA-5654733", "name": "Negative regulation of FGFR4 signaling"}, {"id": "R-HSA-5654736", "name": "Signaling by FGFR1"}, {"id": "R-HSA-5654738", "name": "Signaling by FGFR2"}, {"id": "R-HSA-5654741", "name": "Signaling by FGFR3"}, {"id": "R-HSA-5654743", "name": "Signaling by FGFR4"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5663220", "name": "RHO GTPases Activate Formins"}, {"id": "R-HSA-5673000", "name": "RAF activation"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5675221", "name": "Negative regulation of MAPK pathway"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6804757", "name": "Regulation of TP53 Degradation"}, {"id": "R-HSA-6806003", "name": "Regulation of TP53 Expression and Degradation"}, {"id": "R-HSA-6811558", "name": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"}, {"id": "R-HSA-68875", "name": "Mitotic Prophase"}, {"id": "R-HSA-68877", "name": "Mitotic Prometaphase"}, {"id": "R-HSA-68882", "name": "Mitotic Anaphase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-69206", "name": "G1/S Transition"}, {"id": "R-HSA-69231", "name": "Cyclin D associated events in G1"}, {"id": "R-HSA-69236", "name": "G1 Phase"}, {"id": "R-HSA-69273", "name": "Cyclin A/B1/B2 associated events during G2/M transition"}, {"id": "R-HSA-69275", "name": "G2/M Transition"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69618", "name": "Mitotic Spindle Checkpoint"}, {"id": "R-HSA-69620", "name": "Cell Cycle Checkpoints"}, {"id": "R-HSA-70171", "name": "Glycolysis"}, {"id": "R-HSA-70326", "name": "Glucose metabolism"}, {"id": "R-HSA-71387", "name": "Metabolism of carbohydrates"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8953854", "name": "Metabolism of RNA"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-927802", "name": "Nonsense-Mediated Decay (NMD)"}, {"id": "R-HSA-937061", "name": "TRIF (TICAM1)-mediated TLR4 signaling "}, {"id": "R-HSA-9634600", "name": "Regulation of glycolysis by fructose 2,6-bisphosphate metabolism"}, {"id": "R-HSA-9648025", "name": "EML4 and NUDC in mitotic spindle formation"}, {"id": "R-HSA-9716542", "name": "Signaling by Rho GTPases, Miro GTPases and RHOBTB3"}, {"id": "R-HSA-975138", "name": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"}, {"id": "R-HSA-975155", "name": "MyD88 dependent cascade initiated on endosome"}, {"id": "R-HSA-975871", "name": "MyD88 cascade initiated on plasma membrane"}, {"id": "R-HSA-975957", "name": "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"}, {"id": "R-HSA-9833482", "name": "PKR-mediated signaling"}], "wikipathways": [{"id": "WP1422", "name": "Sphingolipid pathway"}, {"id": "WP231", "name": "TNF-alpha signaling pathway"}, {"id": "WP2380", "name": "Brain-derived neurotrophic factor (BDNF) signaling pathway"}, {"id": "WP2436", "name": "Dopamine metabolism"}, {"id": "WP2857", "name": "Mesodermal commitment pathway"}, {"id": "WP3680", "name": "Association Between Physico-Chemical Features and Toxicity Associated Pathways"}, {"id": "WP3888", "name": "VEGFA-VEGFR2 Signaling Pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP399", "name": "Wnt signaling pathway and pluripotency"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4582", "name": "Cancer immunotherapy by CTLA4 blockade"}, {"id": "WP4767", "name": "FGFR3 signaling in chondrocyte proliferation and terminal differentiation"}, {"id": "WP4949", "name": "16p11.2 proximal deletion syndrome"}, {"id": "WP500", "name": "Glycogen Synthesis and Degradation"}]}, "pdb": ["2IAE", "2IE3", "2IE4", "2NPP", "2NYL", "2NYM", "3C5W", "3DW8", "3FGA", "3K7V", "3K7W", "3P71", "4I5L", "4I5N", "4IYP", "4LAC", "4NY3", "5W0W", "6NTS", "7CUN", "7K36", "7PKS", "7SOY", "7YCX", "8RBX", "8RBZ", "8RC4", "8SO0", "8TTB", "8TWE", "8TWI", "8U1X", "8U89", "8UWB"], "pfam": "PF00149", "pharmgkb": "PA33663", "pharos": {"target_id": 18601, "tdl": "Tchem"}, "pir": "S01986", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF170024", "relationship": "similar to"}, {"id": "GNF254567", "relationship": "is"}, {"id": "GNF254568", "relationship": "is"}, {"id": "GNF254569", "relationship": "is"}, {"id": "GNF254570", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF158672", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF034729", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF011597", "relationship": "is"}, {"id": "GNF011598", "relationship": "is"}, {"id": "GNF030113", "relationship": "is"}, {"id": "GNF131336", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF243102", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF338726", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106621", "relationship": "is"}, {"id": "GNF146267", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000005.10", "NC_060929.1", "NG_046997.2"], "protein": ["NP_001341948.1", "NP_002706.1"], "rna": ["NM_001355019.2", "NM_002715.4", "NR_149151.2"], "translation": [{"protein": "NP_002706.1", "rna": "NM_002715.4"}, {"protein": "NP_001341948.1", "rna": "NM_001355019.2"}]}, "reporter": {"HG-U133_Plus_2": ["208652_at", "235502_at", "238719_at"], "HG-U95Av2": ["237_s_at", "33181_at"], "HG-U95B": "48243_at", "HTA-2_0": "TC05003406.hg.1", "HuEx-1_0": "2876046", "HuGene-1_1": "8114158", "HuGene-2_1": "17000022"}, "summary": "This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes an alpha isoform of the catalytic subunit. [provided by RefSeq, Jul 2008].", "symbol": "PPP2CA", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1335241"}, "unigene": "Hs.105818", "uniprot": {"Swiss-Prot": "P67775", "TrEMBL": ["B3KQ51", "B3KUN1", "E7ESG8", "A0A8V8TQA1", "A0A8V8TRB3", "A0A8V8TQU8", "A0A8V8TRA6"]}, "wikipedia": {"url_stub": "PPP2CA"}}